TGFB1 and neoplasm: In the period of rapid growth (2018-2021), it was the main research topic to explore further some intrinsic mechanisms (including immune checkpoints, TGF-β signaling pathway, NF-kB signaling pathway, and tumor-associated macrophages) to improve the antitumor efficacy of CAR-NK cells.